Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Amicus Therapeutics (FOLD) Prepaid Assets (2016 - 2025)

Historic Prepaid Assets for Amicus Therapeutics (FOLD) over the last 17 years, with Q3 2025 value amounting to $38.5 million.

  • Amicus Therapeutics' Prepaid Assets rose 892.48% to $38.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $38.5 million, marking a year-over-year increase of 892.48%. This contributed to the annual value of $34.9 million for FY2024, which is 2952.38% down from last year.
  • As of Q3 2025, Amicus Therapeutics' Prepaid Assets stood at $38.5 million, which was up 892.48% from $46.3 million recorded in Q2 2025.
  • In the past 5 years, Amicus Therapeutics' Prepaid Assets registered a high of $54.4 million during Q1 2024, and its lowest value of $20.1 million during Q3 2021.
  • Its 5-year average for Prepaid Assets is $38.1 million, with a median of $37.4 million in 2023.
  • Per our database at Business Quant, Amicus Therapeutics' Prepaid Assets soared by 9054.83% in 2022 and then plummeted by 3299.17% in 2024.
  • Over the past 5 years, Amicus Therapeutics' Prepaid Assets (Quarter) stood at $34.8 million in 2021, then increased by 15.38% to $40.2 million in 2022, then rose by 23.19% to $49.5 million in 2023, then fell by 29.52% to $34.9 million in 2024, then rose by 10.16% to $38.5 million in 2025.
  • Its Prepaid Assets was $38.5 million in Q3 2025, compared to $46.3 million in Q2 2025 and $39.5 million in Q1 2025.